Purified talc - Novatech
Alternative Names: NPC-05; Steritalc; UnitalcLatest Information Update: 16 Dec 2021
At a glance
- Originator Novatech
- Developer Nagoya University; Nobelpharma; Novatech
- Class Antiperspirants; Influenza A vaccines; Magnesium silicates
- Mechanism of Action Collagen stimulants; Inflammation mediator stimulants; Interleukin 1 stimulants; Interleukin-8 expression stimulants; Transforming growth factor beta stimulants; Tumour necrosis factor alpha stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Pleural effusion; Pneumothorax
Most Recent Events
- 16 Dec 2021 Preregistration for Pneumothorax in Japan (Intrapleural) (Nobelpharma pipeline, December 2021)
- 16 Dec 2021 Nobelpharma anticipates approval of Purified talc forPneumothorax in March 2022 (Nobelpharma pipeline, December 2021)
- 30 Jul 2019 Phase-II clinical trials in Pneumothorax in Japan (Intrapleural) (Nobelpharma pipeline, July 2019)